Research institutes and pharmaceutical companies developing urgently needed medicines, vaccines and diagnostics to address the global pandemic caused by SARS-CoV-2 must streamline the research and discovery, regulatory approval and commercialization processes. This is true whether they are developing novel treatments or repurposing existing ones.
Join Fox Intellectual Property attorneys Gerard P. Norton, PhD, Jianming Jimmy Hao, PhD, and Nancy Halpern, DVM, and patent agent Joe Chen, PhD, for a free webinar, hosted in conjunction with Princeton Innovation Center BioLabs, focused on COVID-19 precautions, testing and therapeutics, including anti-viral medicines and vaccines.
